Neuroone Medical Technologies (NMTC) Gross Profit Growth (3y) (2014 - 2026)
Neuroone Medical Technologies (NMTC) Gross Profit Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 8.95% |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | 69.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.31% |
| Mar 31, 2026 | 215.60% |
| Dec 31, 2025 | 405.79% |
| Sep 30, 2025 | 369.49% |
| Jun 30, 2025 | 424.94% |
| Mar 31, 2025 | 185.56% |
| Dec 31, 2024 | 430.31% |
| Sep 30, 2024 | 117.12% |
| Jun 30, 2024 | 146.11% |
| Mar 31, 2024 | 173.61% |
| Dec 31, 2023 | 108.56% |
| Jun 30, 2014 | -37.11% |
| Mar 31, 2014 | -62.27% |